+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

US Female Infertility Diagnosis And Treatment Market 2019-2025

  • PDF Icon

    Report

  • January 2020
  • Region: United States
  • Orion Market Research Private Limited
  • ID: 5005510
UP TO OFF until Dec 31st 2022
The US Female Infertility Diagnosis And Treatment Market Size, Share & Trends Analysis Report, By Diagnosis (Ovulation Testing, Hysterosalpingography (HSG), Hysteroscopy, Imaging Testing, Ovarian Reserve Testing, Hormonal Level Testing, Genetic Testing, and Others (Laparoscopy)), By End-User (Hospitals and Clinics, Homecare, and Pathology and Diagnostic Centers), and Forecast 2019-2025.

The US female infertility diagnosis and treatment market is expected to witness a significant growth with the CAGR of 3.8% during the forecast period. The US Female infertility diagnosis and treatment diagnosis and treatment market is growing significantly due to various factors such as increasing infertility rate among females, unhealthy lifestyle and development of new technologies in IVF treatment. Apart from these factors, the rising trend of surrogacy in the country is also driving the growth of the market. According to the American Pregnancy Association in 2017, infertility affects around 6 million American couples, which corresponds to around 10% of American females of childbearing age. In addition, around 25% of infertile couples have more than one cause of infertility. The growing infertility rate creates the demand for infertility diagnosis and treatment, which in turn, drives the market growth.

The US Female infertility diagnosis and treatment market is segmented on the basis of diagnosis, treatment type, and end-user. Based on the diagnosis, the market is segmented into ovulation testing, hysterosalpingography (HSG), hysteroscopy, imaging testing, ovarian reserve testing, hormonal level testing, genetic testing, and others (laparoscopy). Based on the treatment type, the market is segmented into drugs, surgery, intrauterine insemination (IUI), and assisted reproductive technology (ART). Based on the end-user, the market is segmented into hospitals and clinics, homecare, and pathology and diagnostic center.

Some of the major players operating in the US female infertility diagnosis and treatment market include Abbott Laboratories, Inc., Merck KGaA, Cipla Ltd., and others. These players adopt various organic and inorganic growth strategies such as merger and acquisition and product launch to strengthen their presence in The US market.

Research Methodology

The market study of the US female infertility diagnosis and treatment market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for existing companies and new entrants into the market, potential investors and venture capitalists, government organizations, and various end-user industries for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the company and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. The US Female Infertility Diagnosis And Treatment Market Research and Analysis by Diagnosis
2. The US Female Infertility Diagnosis And Treatment Market Research and Analysis by Treatment
3. The US Female Infertility Diagnosis And Treatment Market Research and Analysis by End-User

The Report Covers
  • Comprehensive research methodology of the US female infertility diagnosis and treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the US female infertility diagnosis and treatment market.
  • Insights about market determinants which are stimulating the US female infertility diagnosis and treatment market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight& Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. The US Female Infertility Diagnosis and Treatment Market by Diagnosis
5.1.1. Ovulation Testing
5.1.2. Hysterosalpingography (HSG)
5.1.3. Hysteroscopy
5.1.4. Imaging Testing
5.1.5. Ovarian Reserve Testing
5.1.6. Hormonal Level Testing
5.1.7. Genetic Testing
5.1.8. Others (Laparoscopy)
5.2. The US Female Infertility Diagnosis and Treatment Market by Treatment
5.2.1. Drugs
5.2.2. Surgery
5.2.3. Intrauterine Insemination (IUI)
5.2.4. Assisted Reproductive Technology (ART)
5.3. The US Female Infertility Diagnosis and Treatment Market by End-User
5.3.1. Hospitals and Clinics
5.3.2. Homecare
5.3.3. Pathology and Diagnostic Centers
6. Company Profiles
6.1. Church & Dwight Co.,
6.2. Cook Group Inc
6.3. Eli Lilly Co.
6.4. Fairhaven Health, LLC
6.5. FUJIFILM Irvine Scientific, Inc.,
6.6. Millendo Therapeutics, Inc.
6.7. Pfizer Inc.
6.8. Princeton BioMeditech Corp
6.9. Bayer AG
6.10. Church & Dwight Co., Inc.
6.11. Vitrolife
6.12. Cook Medical, Inc.
6.13. Eli Lilly & Co.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Church & Dwight Co.,
  • Cook Group Inc
  • Eli Lilly Co.
  • Fairhaven Health, LLC
  • FUJIFILM Irvine Scientific, Inc.,
  • Millendo Therapeutics, Inc.
  • Pfizer Inc.
  • Princeton BioMeditech Corp
  • Bayer AG
  • Church & Dwight Co., Inc.
  • Vitrolife
  • Cook Medical, Inc.
  • Eli Lilly & Co.